UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 17, 2017

 

 

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE   1-10765   23-2077891

(State or other jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, PENNSYLVANIA 19406

(Address of principal executive office) (Zip Code)

Registrant’s telephone number, including area code (610) 768-3300

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 17, 2017, Universal Health Services, Inc. (the “Company”) held its 2017 Annual Meeting of Stockholders at the Company’s Corporate Center at 367 South Gulph Road, King of Prussia, Pennsylvania.

At the Annual Meeting, the Company’s stockholders: (i) voted to elect two Class III members of the Board of Directors for three-year terms scheduled to expire at the Company’s 2020 Annual Meeting of Stockholders; (ii) voted to approve the amendment to our Third Amended and Restated 2005 Stock Incentive Plan; (iii) voted in favor of the advisory (nonbinding) vote on named executive officer compensation; (iv) voted in favor of the advisory (nonbinding) stockholder vote to approve named executive officer compensation every three years; (v) voted to ratify the selection of PricewaterhouseCoopers, LLP, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017, and; (vi) voted to reject the shareholder proposal regarding proxy access. The final voting results were as follows:

Proposal No. 1: Election of Directors:

Alan B. Miller – elected by the Class  A and Class  C Stockholders:

 

Votes cast in favor

     7,259,248  

Votes withheld

     0  

Broker non-votes

     0  

Lawrence S. Gibbs – elected by the Class  B and Class  D Stockholders:

 

Votes cast in favor

     69,546,340  

Votes withheld

     5,685,229  

Broker non-votes

     3,706,366  

Proposal No. 2: Approval of an amendment to the Universal Health Services, Inc. Third Amended and Restated 2005 Stock Incentive Plan:

 

Votes cast in favor

     64,606,611  

Votes cast against

     1,486,476  

Votes abstained

     2,553  

Broker non-votes

     419,374  

Proposal No. 3: Conduct an advisory (nonbinding) vote to approve named executive officer compensation:

 

Votes cast in favor

     63,627,444  

Votes cast against

     2,465,273  

Votes abstained

     2,922  

Broker non-votes

     419,374  

Proposal No. 4: Conduct an advisory (nonbinding) vote on the frequency of future advisory stockholder votes to approve named executive officer compensation:

 

1 Year

     5,612,042  

2 Years

     4,090  

3 Years

     60,474,582  

Votes abstained

     4,926  

Broker non-votes

     419,374  


Proposal No. 5: Ratification of the selection of PricewaterhouseCoopers, LLP, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017:

 

Votes cast in favor

     66,491,225  

Votes cast against

     22,675  

Votes abstained

     1,114  

Broker non-votes

     0  

Proposal No. 6: Shareholder proposal related to proxy access:

 

Votes cast in favor

     5,486,370  

Votes cast against

     60,594,085  

Votes abstained

     15,185  

Broker non-votes

     419,374  


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Universal Health Services, Inc.
By:  

/s/ Steve Filton

Name:   Steve Filton
Title:   Executive Vice President and Chief Financial Officer

Date: May 18, 2017

Universal Health Services (NYSE:UHS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Universal Health Services Charts.
Universal Health Services (NYSE:UHS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Universal Health Services Charts.